Physician

Kristine Gade Reed, MD

According to 2025 Medicare claims, Kristine Reed, MD (NPI: 1023405560) practices internal medicine in the Winchester, VA-WV market, with the plurality of this provider's patient population coming from Winchester City, VA. This provider's primary affiliated billing organization is SHENANDOAH ONCOLOGY, PC (NPI: 1124381959; TIN: 454759270) and primary practice location at 22601-6906. Reed is affiliated with the ACO West Virginia (ACO ID: A3563) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Reed's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 561 traditional Medicare patients, billed 157,198 HCPCS/CPT codes, and received $2,874,964 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 809 prescription claims across 143 beneficiaries totaling $1,385,000 in drug costs, led by Kisqali (Ribociclib Succinate). DME data shows 11 claims. Open Payments data shows 10 records totaling $239. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $16,648 to $2,874,964. Similarly, Part D prescription costs have moved sharply higher in recent years, from $8,693 to $1,385,000. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	42	200	$16,648
2019	47	245	$18,998
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	132	19,401	$302,002
2023	395	83,564	$1,478,742
2024	561	157,198	$2,874,964

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	28	81	$8,693
2016	64	348	$78,617
2017	82	433	$51,694
2018	54	325	$32,039
2019	35	153	$14,013
2020	N/R	15	$93
2021	N/R	N/R	N/R
2022	16	47	$55,907
2023	55	253	$288,997
2024	143	809	$1,385,000

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	11	$207

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	173	413	$96
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	146	366	$92
96375	Injection of additional new drug or substance into vein	126	761	$11
80053	Blood test, comprehensive group of blood chemicals	177	522	$10
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	191	611	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Kisqali	Ribociclib Succinate	19	455	$324,945
Lenalidomide	Lenalidomide	13	364	$198,500
Eliquis	Apixaban	35	1,230	$22,227
Potassium Chloride	Potassium Chloride	33	343	$1,451
Anastrozole	Anastrozole	123	6,226	$1,380

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	11	$207

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	10	$239	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kristine Gade Reed, MD?

Tedicare shows public-source Medicare data for Kristine Gade Reed, MD (NPI 1023405560), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kristine Gade Reed, MD have ACO affiliation data?

Kristine Gade Reed, MD is shown with ACO affiliation data for ACO West Virginia (MSSP, ACO ID A3563) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Kristine Gade Reed, MD?

Kristine Gade Reed, MD is linked to SHENANDOAH ONCOLOGY, PC (billing NPI 1124381959) in the available physician profile data.

Does Kristine Gade Reed, MD have Open Payments data?

Kristine Gade Reed, MD has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.